Several recent drug discovery partnerships have been announced that reflect the importance of new technologies and techniques to the efficient development of new therapeutics. ERS Genomics and Université de Montréal ERS Genomics and Université de Montréal (UdeM) have announced an agreement that grants the university access to ERS’ CRISPR/Cas9 patent portfolio – including enabling the […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!